Immunethep
PrivateLast Round
Grant
Apr 2, 2025
Total Funding Raised
$6.49M
Company Overview
Immunethep is a biotechnology company that develops preventive and therapeutic anti-bacterial immunotherapies targeting a shared virulence mechanism in pathogenic bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
immunotherapyanti-bacterial vaccineanti-microbial resistanceAMRsuperbug vaccinebiotechnologydrug discoverymonoclonal antibodiesmAbvaccine developmentinfectious diseasevirulence factorsbiopharmabroad-spectrum vaccinepreclinical research
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunethep Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Immunethep Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 2, 2025 | ||||
| Grant | Feb 25, 2025 | ||||
| Early Funding | Jul 31, 2024 | ||||
| Grant | Oct 18, 2022 | ||||
| Grant | Oct 23, 2017 | ||||
Seed | Apr 13, 2015 |
Immunethep Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Beta Capital | Early Funding |
| Portugal Ventures | Seed |
| IM Gestão de Ativos | Early Funding |
Immunethep Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immunethep's valuation, stock price, and market status.
Firmographic Details
HeadquartersCantanhede
Employee Range22
Year Founded2013
Last FundingApr 2, 2025